首页> 外文期刊>Journal of food and drug analysis >Effects of fermentation treatment on antioxidant and antimicrobial activities of four common Chinese herbal medicinal residues by Aspergillus oryzae
【24h】

Effects of fermentation treatment on antioxidant and antimicrobial activities of four common Chinese herbal medicinal residues by Aspergillus oryzae

机译:发酵处理对米曲霉四种常见中草药残留物抗氧化和抗菌活性的影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The feasibility of using Aspergillus oryzae NCH 42, an extracellular tannase-producing fungus, for increasing the utilization of extraction residues of Chinese herbal medicines (CHMs) was evaluated in this study. Four types of CHMs, including Trichosanthes feirilowii Maxim, Saluia miltiorrhiza Bge, Magnolia qjjicinalis and Glycyrrhizae radix, were used. Their aqueous extraction residues were inoculated with A. oryzae NCH 42, and solid-state fermentation was performed for 5 days at 30 °C with a moisture content of 86% (ratio of solid to water 1:6, w/v). The methanolic extracts of fermentation products (F&M) were examined for their functional components and properties, such as total phenolic content, antioxidant activity and tannin content. All experiments were performed using 0.1% (w/v) extracts, and the antibacterial activities of the 10% (w/v) extracts were tested against seven Gram-positive and Gram-negative bacteria, including Bacillus cereus BCRC 10603, Listeria monocytogenes BCRC 14848, Staphylococcus aureus BCRC 15211, Staphylococcus aureus BCRC 12154, Escherichia coli BCRC 10675, Salmonella enterica BCRC 10747, and Salmonella enterica BCRC 12948. Results showed that fermentation enhanced the release of functional ingredients from the extracts. The F&M products had higher total phenolic content and antioxidant activity than the unfermented ones, but the tannin content was lower. Moreover, the F&M products of each residue showed a wide spectrum of antibacterial activities against the seven pathogenic bacteria tested. These results revealed that solid-state fermentation using A. oryzae NCH 42 improves the utilization of extraction residues of CHMs.
机译:在这项研究中,评价了使用米曲霉NCH 42(一种胞外鞣酸酶)增加中草药提取残留物利用率的可行性。使用了四种类型的CHM,包括Trichosanthes feirilowi​​i Maxim,Saluia miltiorrhiza Bge,Magnolia qjjicinalis和Glycyrrhizae radix。用米曲霉NCH 42接种他们的水提取残留物,并在30°C进行5天的固态发酵,水分含量为86%(固体与水的比例为1:6,w / v)。检查了发酵产物(F&M)的甲醇提取物的功能成分和特性,例如总酚含量,抗氧化活性和单宁含量。所有实验均使用0.1%(w / v)提取物进行,并测试了10%(w / v)提取物对7种革兰氏阳性和革兰氏阴性细菌的抗菌活性,包括蜡样芽胞杆菌BCRC 10603,单核细胞增生李斯特菌BCRC 14848,金黄色葡萄球菌BCRC 15211,金黄色葡萄球菌BCRC 12154,大肠杆菌BCRC 10675,小肠沙门氏菌BCRC 10747和小肠沙门氏菌BCRC12948。结果表明,发酵增强了提取物中功能成分的释放。 F&M产品的总酚含量和抗氧化活性均高于未发酵产品,但单宁含量较低。此外,每种残留物的F&M产品对测试的7种病原菌均具有广泛的抗菌活性。这些结果表明,使用米曲霉NCH 42进行固态发酵可提高CHM提取残渣的利用率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号